Formulation Technology, Inc.January 10, 2020

FDA 483 - Formulation Technology, Inc. - January 10, 2020

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Formulation Technology, Inc.

Record Details

An FDA inspection of Formulation Technology, Inc. in Oakdale, CA, revealed significant deficiencies in data integrity and quality control for their drug manufacturing operations. The firm failed to implement appropriate controls for computer systems used in potency testing, leading to unverified data. Additionally, the Quality Control Unit did not follow established procedures for product quality reviews and preventative maintenance for manufacturing equipment.

Company: Formulation Technology, Inc.
Inspection Date: January 10, 2020
Product Type: Drugs
Office: Division of Human and Animal Food Operations - West V
Person: Scott N. Lim

Open in Dashboard

ID · 8d32d4dc-d6e5-4a3a-8b24-5671f0ff4e09